Creating clinical trial designs that incorporate clinical outcome assessments
نویسندگان
چکیده
منابع مشابه
Developing Personalized Clinical Outcome Assessments
In recent years, patients, advocates, researchers, regulators, and other stakeholders have highlighted the importance of engaging patients more directly in medical product development and the regulatory review process. A key focus of these efforts has been advancing the science of patient input: identifying rigorous, systematic approaches to incorporating patient perspectives in medical product...
متن کاملBiomarker informed adaptive clinical trial designs
In adaptive design clinical trials, an endpoint at the final analysis that takes a long time to observe is not feasible to be used for making decisions at the interim analysis. For example, overall survival (OS) in oncology trials usually cannot be used to make interim decisions. However, biomarkers correlated to the final clinical endpoint can be used. Hence, considerable interest has been dra...
متن کاملClinical trial designs for targeted agents.
With an increasing number of targeted agents available for testing, clinical trials must be rationally designed based on sound knowledge of the molecular mechanisms linking target and disease, fortified by strong preclinical data demonstrating how this relationship is modified by the targeted agent. Patients and resources are precious and should be expended judiciously on clinical trials that a...
متن کاملClinical trial designs for therapeutic cancer vaccines.
Therapeutic cancer vaccines have characteristics that require a new paradigm for phase I and phase II clinical development. Effective development plans may take advantage of some of the following observations: Dose ranging safety trials are not appropriate for many cancer vaccines. Dose ranging trials to establish an optimal biologic dose are often not practical. We have presented an efficient ...
متن کاملResponse Adaptive Designs that Incorporate Switching Costs and Constraints
This paper examines the design and performance of sequential experiments where extensive switching is undesirable. Given an objective function to optimize by sampling between Bernoulli populations, two different models are considered. The constraint model restricts the maximum number of switches possible, while the cost model introduces a charge for each switch. Optimal allocation procedures an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2016
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/nov254